115 related articles for article (PubMed ID: 1477300)
1. High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential.
Looney JE; Knight DM; Arevalo-Moore M; Trinh H; Pak KY; Dalesandro MR; Rieber EP; Riethmuller G; Daddona PE; Ghrayeb J
Hum Antibodies Hybridomas; 1992 Oct; 3(4):191-200. PubMed ID: 1477300
[TBL] [Abstract][Full Text] [Related]
2. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
3. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
[TBL] [Abstract][Full Text] [Related]
5. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.
Nishimura Y; Yokoyama M; Araki K; Ueda R; Kudo A; Watanabe T
Cancer Res; 1987 Feb; 47(4):999-1005. PubMed ID: 2948638
[TBL] [Abstract][Full Text] [Related]
7. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
Heinrich G; Gram H; Kocher HP; Schreier MH; Ryffel B; Akbar A; Amlot PL; Janossy G
J Immunol; 1989 Dec; 143(11):3589-97. PubMed ID: 2479683
[TBL] [Abstract][Full Text] [Related]
10. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
11. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
[TBL] [Abstract][Full Text] [Related]
12. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
[TBL] [Abstract][Full Text] [Related]
14. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
15. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
16. Construction and expression of mouse-human chimeric antibody SZ-51 specific for activated platelet P-selectin.
Gu J; Liu Y; Xia L; Wan H; Li P; Zhang X; Ruan C
Thromb Haemost; 1997 Apr; 77(4):755-9. PubMed ID: 9134655
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of cM-T413, a chimeric anti-CD4 antibody with in vitro immunosuppressive activity.
Looney JE; Willinger A; Lin G; Rieber EP; Riethmuller G; Ghrayeb J
J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):36-46. PubMed ID: 8081558
[TBL] [Abstract][Full Text] [Related]
18. Construction, expression, and biologic activity of murine/human chimeric antibodies with specificity for the human alpha/beta T cell receptor.
Shearman CW; Kanzy EJ; Lawrie DK; Li YW; Thammana P; Moore GP; Kurrle R
J Immunol; 1991 Feb; 146(3):928-35. PubMed ID: 1824850
[TBL] [Abstract][Full Text] [Related]
19. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
[TBL] [Abstract][Full Text] [Related]
20. Cloning and expression of a chimeric antibody directed against the human transferrin receptor.
Hoogenboom HR; Raus JC; Volckaert G
J Immunol; 1990 Apr; 144(8):3211-7. PubMed ID: 2324499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
